DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 163 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $541,680 | -10.2% | 42,585 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $603,453 | -8.1% | 42,859 | +0.8% | 0.00% | 0.0% |
| Q1 2023 | $656,686 | -57.6% | 42,504 | -55.1% | 0.00% | -66.7% |
| Q4 2022 | $1,549,968 | -7.6% | 94,568 | +4.2% | 0.00% | -25.0% |
| Q3 2022 | $1,678,000 | +68.5% | 90,754 | +19.6% | 0.00% | +100.0% |
| Q2 2022 | $996,000 | +643.3% | 75,858 | +422.9% | 0.00% | – |
| Q1 2022 | $134,000 | -26.4% | 14,507 | -22.6% | 0.00% | – |
| Q4 2021 | $182,000 | -93.9% | 18,755 | -78.8% | 0.00% | -100.0% |
| Q3 2021 | $3,000,000 | -23.6% | 88,345 | -17.7% | 0.01% | -28.6% |
| Q2 2021 | $3,928,000 | +19.5% | 107,342 | +46.3% | 0.01% | +16.7% |
| Q1 2021 | $3,287,000 | +35.8% | 73,347 | +72.9% | 0.01% | +20.0% |
| Q4 2020 | $2,420,000 | +17.4% | 42,422 | +5.4% | 0.01% | +25.0% |
| Q3 2020 | $2,062,000 | +1098.8% | 40,241 | +1290.0% | 0.00% | – |
| Q2 2020 | $172,000 | -70.0% | 2,895 | -89.4% | 0.00% | -100.0% |
| Q4 2018 | $574,000 | -51.6% | 27,318 | -10.9% | 0.00% | -50.0% |
| Q3 2018 | $1,187,000 | -31.6% | 30,654 | -30.5% | 0.00% | -50.0% |
| Q2 2018 | $1,736,000 | +96.4% | 44,098 | 0.0% | 0.00% | +300.0% |
| Q1 2018 | $884,000 | – | 44,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |